MEISi-2 is a small-molecule, selective inhibitor of MEIS transcription factors developed for research into hematopoietic stem cell self-renewal, cardiac injury, bone marrow transplantation, and cancer. Supplied as a high-purity research reagent, it is intended for in vitro screening and mechanistic studies.
- Selective MEIS transcription factor inhibition for target validation.
- High purity suitable for biochemical and cell-based assays.
- Small pack size ideal for screening and pilot experiments.
- Molecular weight 306.32 g/mol and formula C18H14N2O3 for accurate dosing calculations.
- Supplied with CAS number 2250156-71-7 for unambiguous identification.